Indivior Pharmaceuticals Inc
INDV
Rang în acțiuni
#3881
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Preț acțiune
$34.01
Ultima sincronizare: 2026-10-19
Capitalizare de piață
$4.24B
Schimbare (1 zi)
4.81%
Schimbare (1 an)
40.02%
Țară
US
Tranzacționează Indivior Pharmaceuticals Inc (INDV)
Categorie
Healthcare
Raport P/B pentru Indivior Pharmaceuticals Inc (INDV)
Raport P/B la data de October 2026 TTM: -20.59
Conform celor mai recente rapoarte financiare și prețului acțiunilor Indivior Pharmaceuticals Inc, raportul P/B actual (TTM) este -20.59. La sfârșitul anului 2023, compania avea un P/B de 31.28.
Istoricul raportului P/B pentru Indivior Pharmaceuticals Inc din 2016 până în 2026
Raport P/B la sfârșitul fiecărui an
| An | Raport P/B | Schimbă |
|---|---|---|
| 2026 (TTM) | -20.59 | 337.08% |
| 2024 | -4.71 | -115.07% |
| 2023 | 31.28 | -46.95% |
| 2022 | 58.97 | 375.46% |
| 2021 | 12.40 | -5.60% |
| 2020 | 13.14 | 623.09% |
| 2019 | 1.82 | -87.78% |
| 2018 | 14.87 | -176.13% |
| 2017 | -19.54 | 125.54% |
| 2016 | -8.66 | 0.00% |
Raport P/B pentru companii similare sau competitoare
| Companie | Raport P/B | Diferență raport P/B | Țara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -124.49% |
IN
|
